Related Experiment Video
Updated: May 17, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
[Radionuclide evaluation of renal function in essential hypertensive patients with chronic kidney disease]
Insights
Radionuclide imaging using dynamic nephroscintigraphy detects early kidney dysfunction in patients with arterial hypertension and chronic kidney disease. This method offers prognostic value for assessing renal impairment and guiding timely treatment.
Area of Science:
- Nephrology
- Nuclear Medicine
- Cardiology
Background:
- Arterial hypertension (AH) and chronic kidney disease (CKD) are significant comorbidities.
- Assessing renal function in AH patients with CKD is crucial for management.
- Radionuclide imaging offers a non-invasive method for evaluating kidney function.
Purpose of the Study:
- To evaluate renal function using radionuclide methods in patients with arterial hypertension and chronic kidney disease.
- To compare renal function in patients with AH and CKD versus CKD patients without AH.
- To investigate the relationship between glomerular filtration rate (GFR) and renal secretory/excretory function.
Main Methods:
- Dynamic nephroscintigraphy was performed on 31 patients with AH and CKD.
- A control group of 8 CKD patients without AH was included.
- Scintigraphic data were analyzed to assess renal secretory and excretory phases.
Main Results:
- Statistically significant differences in renal secretory and excretory functions were observed in AH patients with CKD.
- A deceleration in the secretory phase was noted when GFR was 30-59 ml/min.
- An acceleration in secretory function, indicated by a 3-fold reduction in peak radio tracer concentration, occurred when GFR was below 30 ml/min (p < 0.001).
Conclusions:
- Dynamic nephroscintigraphy effectively detects early renal secretory and excretory dysfunctions.
- The technique provides prognostic value in assessing the severity of renal dysfunction.
- Early identification of these dysfunctions necessitates timely pharmacological intervention.
Aim:
To carry out radionuclide evaluation of renal function in patients with arterial hypertension (AH) and chronic kidney disease (CKD).
Subjects And Methods:
Thirty-one AH patients with CKD were examined using dynamic nephroscintigraphy. A control group consisted of 8 CKD patients without AH.
Results:
The scintigraphic findings reflected statistically significant differences in renal secretory and excretory functions depending on the level of glomerular filtration rate (GFR) decrease in AH patients with CKD. If GFR was 30-59 ml/min, there was a deceleration in the secretory phase in the histogram; but when it was lower than 30 ml/min, the secretory function tended to accelerate, which appeared as a 3-fold reduction in achieving the peak radio tracer concentration (p < 0.001).
Conclusion:
Dynamic nephroscintigraphy can detect early renal secretory and excretory dysfunctions and it is of prognostic value in assessing renal dysfunction, which necessitates early drug correction of revealed disorders.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...

